SHANGHAI, Feb. 10, 2026 /PRNewswire/ -- As China's new drug R&D enters the "deep waters" of homogeneous competition, the path for followers has become increasingly crowded. Target congestion, rising ...
The panel assembled and analyzed underlying data on research and development (R&D), science and technology (S&T), human capital, and innovation to determine the following: This appendix describes the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results